Chitosan prevents the development of AOM-induced aberrant crypt foci in mice and suppressed the proliferation of AGS cells by inhibiting DNA synthesis

Journal of Cellular Biochemistry

Volumn 100, Issue 6, 2007, Pages 1573-1580

  Lin, Shyr Yi ^a   Chan, Hing Yuen ^b   Shen, Fung Hsiu ^c   Chen, Mei Huei ^b   Wang, Ying Jan ^c   Yu, Chung Keung ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Anti tumorigenicity; Cell cycle; Cells proliferation; Chitosan

Indexed keywords

AZOXYMETHANE; BROXURIDINE; CHITOSAN; CHITOSAN DERIVATIVE; DNA; OLIGOMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER THERAPY; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; CRYPT CELL; DNA SYNTHESIS INHIBITION; FLOW CYTOMETRY; GENE; GENE CONTROL; HUMAN; HUMAN CELL; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; P21 CIP GENE; P27 KIP GENE; PCNA GENE; PRECANCER; PRIORITY JOURNAL; STOMACH CANCER;

ANIMALS; AZOXYMETHANE; BLOTTING, WESTERN; CARCINOGENS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHITOSAN; COLONIC NEOPLASMS; DNA REPLICATION; FLOW CYTOMETRY; HUMANS; JURKAT CELLS; MALE; MICE; MICE, INBRED ICR; MOLECULAR WEIGHT; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS; TIME FACTORS; URINARY BLADDER NEOPLASMS;

MUS;

EID: 34047097273     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21152     Document Type: Article

References (39)

1. Acikgoz M, Kas HS, Hascelik Z, Milli U, Hincal AA. 1995. Chitosan microspheres of diclofenac sodium, II: In vitro and in vivo evaluation. Pharmazie 50:275-277.
2. anonymous. 1997. The World Health report 1996-fighting disease, fostering development. World Health Forum 18:1-8.
3. Arroyo-Begovich A, Carabez-Trejo A, Ruiz-Herrera J. 1978. [Composition of the cell wall of Entamoeba invadens cysts]. Arch Invest Med (Mex) 9(Suppl 1):99-104.
4. Bailar JC 3rd, Gornik HL. 1997. Cancer undefeated.[see comment]. N Engl J Med 336:1569-1574.
5. Bird RP. 1987. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings. Cancer Letters 37:147-151.
6. Bird RP. 1995. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 93:55-71.
7. Bird RP, McLellan EA, Bruce WR. 1989. Aberrant crypts, putative precancerous lesions, in the study of the role of diet in the aetiology of colon cancer. Cancer Surv 8:189-200.
8. Burkitt DP. 1971. Epidemiology of cancer of the colon and rectum. Cancer 28:3-13.
9. Chen CS, Liau WY, Tsai GJ. 1998. Antibacterial effects of N-sulfonated and N-sulfobenzoyl chitosan and application to oyster preservation. J Food Prot 61:1124-1128.
10. Dahm K, Hubscher U. 2002. Colocalization of human Rad17 and PCNA in late S phase of the cell cycle upon replication block. Oncogene 21:7710-7719.
11. Gallaher DD, Locket PL, Gallaher CM. 1992. Bile acid metabolism in rats fed two levels of corn oil and brans of oat, rye and barley and sugar beet fiber. J Nutr 122:473-481.
12. Greenwald P, Lanza E, Eddy GA. 1987. Dietary fiber in the reduction of colon cancer risk. J Am Diet Assoc 87:1178-1188.
13. Harris PJ, Roberton AM, Watson ME, Triggs CM, Ferguson LR. 1993. The effects of soluble-fiber polysaccharides on the adsorption of a hydrophobic carcinogen to an insoluble dietary fiber. Nutr Cancer 19:43-54.
14. Hasegawa M, Yagi K, Iwakawa S, Hirai M. 2001. Chitosan induces apoptosis via caspase-3 activation in bladder tumor cells. Jpn J Cancer Res 92:459-466.
15. Ho YS, Lee HM, Mou TC, Wang YJ, Lin JK. 1997. Suppression of nitric oxide-induced apoptosis by N-acetyl-L-cysteine through modulation of glutathione, bcl-2, and bax protein levels. Mol Carcinog 19:101-113.
16. Ho YS, Wu CH, Chou HM, Wang YJ, Tseng H, Chen CH, Chen LC, Lee CH, Lin SY. 2005. Molecular mechanisms of econazole-induced toxicity on human colon cancer cells: G0/G1 cell cycle arrest and caspase 8-independent apoptotic signaling pathways. Food Chem Toxicol 43:1483-1495.
17. Illum L. 1998. Chitosan and its use as a pharmaceutical excipient. Pharm Res 15:1326-1331.
18. Kafetzopoulos D, Martinou A, Bouriotis V. 1993. Bioconversion of chitin to chitosan: Purification and characterization of chitin deacetylase from Mucor rouxii. Proc Natl Acad Sci USA 90:2564-2568.
19. Kas HS. 1997. Chitosan: Properties, preparations and application to microparticulate systems. J Microencapsul 14:689-711.
20. Kim YI. 2000. AGA technical review: Impact of dietary fiber on colon cancer occurrence. Gastroenterology 118:1235-1257.
21. Levi MS, Borne RF, Williamson JS. 2001. A review of cancer chemopreventive agents. Curr Medicinal Chem 8:1349-1362.
22. Lin SY, Liang YC, Ho YS, Tsai SH, Pan S, Lee WS. 2002. Involvement of both extracellular signal-regulated kinase and c-jun N-terminal kinase pathways in the 12-O-tetradecanoylphorbol-13-acetate-induced upregulation of p21(Cip1) in colon cancer cells. Mol Carcinog 35:21-28.
23. Lopez-Romero E, Ruiz-Herrera J. 1978. Properties of beta-glucan synthetase from Saccharomyces cerevisiae. Antonie Van Leeuwenhoek 44:329-339.
24. Maeda Y, Kimura Y. 2004. Antitumor effects of various low-molecular-weight chitosans are due to increased natural killer activity of intestinal intraepithelial lymphocytes in sarcoma 180-bearing mice. J Nutr 134:945-950.
25. Marks F, Furstenberger G. 2000. Cancer chemoprevention through interruption of multistage carcinogenesis. The lessons learnt by comparing mouse skin carcinogenesis and human large bowel cancer. Eur J Cancer 36:314-329.
26. McLellan EA, Medline A, Bird RP. 1991. Dose response and proliferative characteristics of aberrant crypt foci: Putative preneoplastic lesions in rat colon. Carcinogenesis 12:2093-2098.
27. Murata J, Saiki I, Makabe T, Tsuta Y, Tokura S, Azuma I. 1991. Inhibition of tumor-induced angiogenesis by sulfated chitin derivatives. Cancer Res 51:22-26.
28. Naderi S, Wang JY, Chen TT, Gutzkow KB, Blomhoff HK. 2005. cAMP-mediated inhibition of DNA replication and S phase progression: Involvement of Rb, p21Cip1, and PCNA. Mol Biol Cell 16:1527-1542.
29. Ogryzko VV, Wong P, Howard BH. 1997. WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases. Mol Cell Biol 17:4877-4882.
30. Ohe T. 1996. Antigenotoxic activities of chitin and chitosan as assayed by sister chromatid exchange. Sci Total Environ 181:1-5.
31. Okamoto Y, Shibazaki K, Minami S, Matsuhashi A, Tanioka S, Shigemasa Y. 1995. Evaluation of chitin and chitosan on open would healing in dogs. J Vet Med Sci 57:851-854.
32. Rane KD, Hoover DG. 1993. An evaluation of alkali and acid treatments for chitosan extraction from fungi. Process Biochem 28:115-118.
33. Singla AK, Chawla M. 2001. Chitosan: Some pharmaceutical and biological aspects-an update. J Pharm Pharmacol 53:1047-1067.
34. Sugano M, Watanabe S, Kishi A, Izume M, Ohtakara A. 1988. Hypocholesterolemic action of chitosans with different viscosity in rats. Lipids 23:187-191.
35. Tan SC, Khor E, Tan TK, Wong SM. 1998. The degree of deacetylation of chitosan: Advocating the first derivative UV-spectrophotometry method of determination. Talanta 45:713-719.
36. Tanaka T, Makita H, Kawabata K, Mori H, Kakumoto M, Satoh K, Hara A, Sumida T, Tanaka T, Ogawa H. 1997. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis 18:957-965.
37. Thorup I, Meyer O, Kristiansen E. 1994. Influence of a dietary fiber on development of dimethylhydrazine-induced aberrant crypt foci and colon tumor incidence in Wistar rats. Nutr Cancer 21:177-182.
38. Tokoro A, Tatewaki N, Suzuki K, Mikami T, Suzuki S, Suzuki M. 1988. Growth-inhibitory effect of hexa-N-acetylchitohexaose and chitohexaose against Meth-A solid tumor. Chem Pharm Bull (Tokyo) 36:784-790.
39. Torzsas TL, Kendall CW, Sugano M, Iwamoto Y, Rao AV. 1996. The influence of high and low molecular weight chitosan on colonic cell proliferation and aberrant crypt foci development in CF1 mice. Food Chem Toxicol 34:73-77.